Iyer MR[au] - Search Results

Year	Number of Results
1994	1
1997	1
1998	1
2003	1
2005	1
2006	1
2007	1
2008	2
2009	4
2010	1
2011	1
2012	2
2013	2
2014	3
2015	3
2016	1
2017	3
2018	2
2019	3
2020	4
2021	9
2022	6
2023	11
2024	1

1

Therapeutic approaches targeting the neurotensin receptors.

Iyer MR, Kunos G. Iyer MR, et al. Expert Opin Ther Pat. 2021 May;31(5):361-386. doi: 10.1080/13543776.2021.1866539. Epub 2021 Jan 8. Expert Opin Ther Pat. 2021. PMID: 33393392 Review.

2

Promising Schiff bases in antiviral drug design and discovery.

Kaushik S, Paliwal SK, Iyer MR, Patil VM. Kaushik S, et al. Among authors: iyer mr. Med Chem Res. 2023;32(6):1063-1076. doi: 10.1007/s00044-023-03068-0. Epub 2023 May 10. Med Chem Res. 2023. PMID: 37305208 Free PMC article. Review.

3

Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.

Bhattacharjee P, Rutland N, Iyer MR. Bhattacharjee P, et al. Among authors: iyer mr. J Med Chem. 2022 Dec 22;65(24):16062-16098. doi: 10.1021/acs.jmedchem.2c01265. Epub 2022 Dec 6. J Med Chem. 2022. PMID: 36473091 Review.

4

Recent progress in the discovery of ghrelin O-acyltransferase (GOAT) inhibitors.

Iyer MR, Wood CM, Kunos G. Iyer MR, et al. RSC Med Chem. 2020 Sep 4;11(10):1136-1144. doi: 10.1039/d0md00210k. eCollection 2020 Oct 1. RSC Med Chem. 2020. PMID: 33479618 Free PMC article. Review.

5

The therapeutic potential of second and third generation CB₁R antagonists.

Cinar R, Iyer MR, Kunos G. Cinar R, et al. Among authors: iyer mr. Pharmacol Ther. 2020 Apr;208:107477. doi: 10.1016/j.pharmthera.2020.107477. Epub 2020 Jan 9. Pharmacol Ther. 2020. PMID: 31926199 Free PMC article. Review.

6

Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade.

Iyer MR, Kundu B, Wood CM. Iyer MR, et al. Expert Opin Ther Pat. 2022 Jun;32(6):629-647. doi: 10.1080/13543776.2022.2054329. Epub 2022 Apr 12. Expert Opin Ther Pat. 2022. PMID: 35410559 Review.

7

Rational Design, Synthesis, and Evaluation of Fluorescent CB₂ Receptor Ligands for Live-Cell Imaging: A Comprehensive Review.

Bhattacharjee P, Iyer MR. Bhattacharjee P, et al. Among authors: iyer mr. Pharmaceuticals (Basel). 2023 Aug 31;16(9):1235. doi: 10.3390/ph16091235. Pharmaceuticals (Basel). 2023. PMID: 37765043 Free PMC article. Review.

8

A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade.

Kundu B, Iyer MR. Kundu B, et al. Among authors: iyer mr. Expert Opin Ther Pat. 2023 Oct;33(10):651-668. doi: 10.1080/13543776.2023.2287515. Epub 2024 Jan 10. Expert Opin Ther Pat. 2023. PMID: 38037334 Review.

9

Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d₃ )butanamide-d₅ , octadeuterated JD5037.

Iyer MR, Cinar R, Coffey NJ, Chorvat RJ, Kunos G. Iyer MR, et al. J Labelled Comp Radiopharm. 2017 Aug;60(10):460-465. doi: 10.1002/jlcr.3521. Epub 2017 Aug 2. J Labelled Comp Radiopharm. 2017. PMID: 28545167 Free PMC article.

10

Crystal Structure of the Human Cannabinoid Receptor CB2.

Li X, Hua T, Vemuri K, Ho JH, Wu Y, Wu L, Popov P, Benchama O, Zvonok N, Locke K, Qu L, Han GW, Iyer MR, Cinar R, Coffey NJ, Wang J, Wu M, Katritch V, Zhao S, Kunos G, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ. Li X, et al. Among authors: iyer mr. Cell. 2019 Jan 24;176(3):459-467.e13. doi: 10.1016/j.cell.2018.12.011. Epub 2019 Jan 10. Cell. 2019. PMID: 30639103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year